CAPTRUST FINANCIAL ADVISORS - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$14,000
+100.0%
1,039
+34.6%
0.00%
Q1 2022$7,000
-36.4%
772
-33.9%
0.00%
Q4 2021$11,000
-59.3%
1,168
+49.7%
0.00%
Q3 2021$27,000
+68.8%
780
+74.9%
0.00%
Q2 2021$16,000
-20.0%
446
+1.1%
0.00%
Q1 2021$20,0004410.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders